Focus:
UK-based biotechnology firm Tiziana Life Sciences has executed an agreement with STC Biologics for the manufacture of TZLS-501 for clinical studies in Covid-19 patients.
Roche has received approval from the US Food and Drug Administration (FDA) for Phesgo, in combination with intravenous (IV) chemotherapy, to treat early and metastatic human epidermal growth factor receptor...
Gilead Sciences has set the price of its investigational Covid-19 drug remdesivir at $390 per vial for the US and governments of other developed countries.
Japan's Ministry of Health, Labour and Welfare has granted the first regulatory approval for GlaxoSmithKline (GSK)'s Duvroq (daprodustat) to treat anaemia caused by chronic kidney disease (CKD).
Brazil has entered an agreement worth $127m to manufacture a Covid-19 vaccine candidate which was developed by the University of Oxford and licensed to AstraZeneca.
Remote working or working from home has become the new norm during the COVID-19 times which call for maintaining physical distancing and complying with lockdown measures to curb disease spread.
Korean biopharmaceutical firm Samsung Bioepis has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for Aybintio, a biosimilar...
Japanese pharmaceutical company Daiichi Sankyo has entered an agreement for discussions with AstraZeneca for the supply of a Covid-19 vaccine candidate, being developed in alliance with the University of Oxford,...
US-based biotech firm Avalon GloboCare has collaborated with the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria to develop an S-layer vaccine against Covid-19 for intranasal or...
Moderna has collaborated with manufacturing solutions provider Catalent for large-scale, commercial fill-finish manufacturing of its Covid-19 vaccine candidate, mRNA-1273.
